A Review of Artificial Intelligence Applications in Epilepsy: From Misdiagnosis to Precision Care

Background and Objective The misdiagnosis of epilepsy is a problem that 25-30% of patients all around the world have to deal with, which results in the use of incorrect treatments, imposing restrictions on life unnecessarily, and making other underlying conditions' care delayed. The limitations of the classic techniques are the subjectivity of EEG interpretation, 20-30% inter-observer variability, and ictal phenomena being only partially captured. This review evaluates thoroughly the potential of using artificial intelligence (AI) for detection of seizures and epilepsy management individually in order to tackle the diagnostic problems. Methodology: A detailed review of the literature has been done to consider the AI interventions in different areas, including deep learning-based EEG signal processing, computer vision for semiological characterization, new wearable biosensors, and machine learning methods to improve personalized treatment. The assessments of effectiveness focused on diagnostic accuracy, clinical validity, and the practicality of real-world implementation Results: AI offers a practical solution for addressing misdiagnosis and advancing precision medicine in epilepsy treatment. There is enough evidence to support the prompt use of validated AI technology in clinical settings. This can enhance diagnosis accuracy, help tailor treatments for individual patients, and ensure broad access to quality epilepsy care. The presence of enforceable regulations, demonstrated effectiveness in clinical trials, and the pressing need to improve the lives of those impacted by epilepsy all support a teamwork-based approach to incorporating AI into regular clinical practice for epilepsy care. Conclusions: AI marks a paradigm shift from misdiagnosis to precision medicine to maximize care for patients with epilepsy. There is evidence to support the immediate utilization of innovative AI technology developed to improve diagnostic accuracy, specify and optimize treatment for individuals with epilepsy, and disseminate high-quality expert care to all patients, regardless of geography. The convergence of regulatory approval, proof of utility, and synthesized clinical need compel us to adopt a systematic integration of AI into daily practice for epilepsy.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24359874
Primary Topic
EEG and Brain-Computer Interfaces
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Review of Artificial Intelligence Applications in Epilepsy: From Misdiagnosis to Precision Care

Arivalagan Rajkumar, Prithiviraj A
Zenodo (CERN European Organization for Nuclear Research)
EEG and Brain-Computer Interfaces
article

A Review of Artificial Intelligence Applications in Epilepsy: From Misdiagnosis to Precision Care

Arivalagan Rajkumar, Prithiviraj A
article en

Abstract

Background and Objective The misdiagnosis of epilepsy is a problem that 25-30% of patients all around the world have to deal with, which results in the use of incorrect treatments, imposing restrictions on life unnecessarily, and making other underlying conditions' care delayed. The limitations of the classic techniques are the subjectivity of EEG interpretation, 20-30% inter-observer variability, and ictal phenomena being only partially captured. This review evaluates thoroughly the potential of using artificial intelligence (AI) for detection of seizures and epilepsy management individually in order to tackle the diagnostic problems. Methodology: A detailed review of the literature has been done to consider the AI interventions in different areas, including deep learning-based EEG signal processing, computer vision for semiological characterization, new wearable biosensors, and machine learning methods to improve personalized treatment. The assessments of effectiveness focused on diagnostic accuracy, clinical validity, and the practicality of real-world implementation Results: AI offers a practical solution for addressing misdiagnosis and advancing precision medicine in epilepsy treatment. There is enough evidence to support the prompt use of validated AI technology in clinical settings. This can enhance diagnosis accuracy, help tailor treatments for individual patients, and ensure broad access to quality epilepsy care. The presence of enforceable regulations, demonstrated effectiveness in clinical trials, and the pressing need to improve the lives of those impacted by epilepsy all support a teamwork-based approach to incorporating AI into regular clinical practice for epilepsy care. Conclusions: AI marks a paradigm shift from misdiagnosis to precision medicine to maximize care for patients with epilepsy. There is evidence to support the immediate utilization of innovative AI technology developed to improve diagnostic accuracy, specify and optimize treatment for individuals with epilepsy, and disseminate high-quality expert care to all patients, regardless of geography. The convergence of regulatory approval, proof of utility, and synthesized clinical need compel us to adopt a systematic integration of AI into daily practice for epilepsy.

Zenodo (CERN European Organization for Nuclear Research)
EEG and Brain-Computer Interfaces
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon